Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Potential Stock-Moving Drug Events In The Second Half Of 2016
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Submitted by
admin
on July 1, 2016 - 10:07am
Source:
Investors.com
News Tags:
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Headline:
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Do Not Allow Advertisers to Use My Personal information
